Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels.

Source:http://linkedlifedata.com/resource/pubmed/id/21069318

Download in:

View as

General Info

PMID
21069318